Characterization of an FcγRI-binding peptide selected by phage display

被引:11
作者
Berntzen, G
Brekke, OH
Mousavi, SA
Andersen, JT
Michaelsen, TE
Berg, T
Sandlie, I [1 ]
Lauvrak, V
机构
[1] Univ Oslo, Dept Mol Biosci, Oslo, Norway
[2] Dynal Biotech ASA, Oslo, Norway
[3] Norwegian Inst Publ Hlth, Oslo, Norway
关键词
cell internalization; Fc gamma receptors; peptide selection; phage display; U937; cells;
D O I
10.1093/protein/gzj011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high-affinity IgG receptor, Fc gamma receptor I (Fc gamma RI), is expressed exclusively on myeloid cells, and there is a great interest in the targeting of vaccine antigens to Fc gamma RI using anti-human Fc gamma RI antibodies or fragments derived from such molecules. In order to reduce the size and complexity of the targeting reagent, we have searched for Fc gamma RI binding peptides in peptide libraries displayed on phage. The human monocytic cell line U937 was used as target. Phages that displayed the consensus peptide CLRSGXGC were selected and revealed increased binding to IFN-gamma stimulated versus non-stimulated U937 cells as well as to Fc gamma RI transfected versus non-transfected IIA1.6 cells. Furthermore, they bound the extracellular domains of soluble Fc gamma RI, but neither Fc gamma RIIA, Fc gamma RIIB nor Fc gamma RIIIB. Binding was inhibited by a synthetic version of the peptide, whereas neither human IgG nor the Fc gamma RI-specific monoclonal antibodies (mAb) mAb22 and 32.2 interfered. Flow-cytometry analysis and internalization studies showed that a synthetic biotin-conjugated peptide ADGACLRSGRGCGAAK-bio was able to target U937 cells and Fc gamma RI transfected IIA1.6 cells, and further to promote internalization and vesicular degradation of streptavidin coupled to 1 mu m magnetic beads. These peptides may have potential as Fc gamma RI targeting reagents.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 37 条
[1]   Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells [J].
Berntzen, G ;
Lunde, E ;
Flobakk, M ;
Andersen, JT ;
Lauvrak, V ;
Sandlie, I .
JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 298 (1-2) :93-104
[2]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[3]   Fc receptor biology [J].
Daeron, M .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :203-234
[4]   Inflammation in autoimmunity: receptors for IgG revisited [J].
Dijstelbloem, HM ;
van de Winkel, JGJ ;
Kallenberg, CGM .
TRENDS IN IMMUNOLOGY, 2001, 22 (09) :510-516
[5]  
Fanger NA, 1997, J IMMUNOL, V158, P3090
[6]   The IgG Fc receptor family [J].
Gessner, JE ;
Heiken, H ;
Tamm, A ;
Schmidt, RE .
ANNALS OF HEMATOLOGY, 1998, 76 (06) :231-248
[7]  
GUYRE PM, 1989, J IMMUNOL, V143, P1650
[8]   RECOMBINANT IMMUNE INTERFERON INCREASES IMMUNOGLOBULIN-G FC-RECEPTORS ON CULTURED HUMAN MONONUCLEAR PHAGOCYTES [J].
GUYRE, PM ;
MORGANELLI, PM ;
MILLER, R .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :393-397
[9]   Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice [J].
Heijnen, IAFM ;
vanVugt, MJ ;
Fanger, NA ;
Graziano, RF ;
deWit, TPM ;
Hofhuis, FMA ;
Guyre, PM ;
Capel, PJA ;
Verbeek, JS ;
vandeWinkel, JGJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :331-338
[10]   A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+advanced prostate cancer [J].
James, ND ;
Atherton, PJ ;
Jones, J ;
Howie, AJ ;
Tchekmedyian, S ;
Curnow, RT .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :152-156